Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines
Mohammad M. Pourseif, Sepideh Parvizpour, Behzad Jafari, et al.
Bioimpacts (2020) Vol. 11, Iss. 1, pp. 65-84
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Designing multi-epitope vaccine against Staphylococcus aureus by employing subtractive proteomics, reverse vaccinology and immuno-informatics approaches
Muhammad Tahir ul Qamar, Sajjad Ahmad, Israr Fatima, et al.
Computers in Biology and Medicine (2021) Vol. 132, pp. 104389-104389
Closed Access | Times Cited: 111
The use of RNA-based treatments in the field of cancer immunotherapy
Mohammad Chehelgerdi, Matin Chehelgerdi
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 85
Morphological Characterization of Self-Amplifying mRNA Lipid Nanoparticles
Jacob L. Thelen, Wellington Leite, Volker S. Urban, et al.
ACS Nano (2024) Vol. 18, Iss. 2, pp. 1464-1476
Closed Access | Times Cited: 19
A contemporary review on the important role of in silico approaches for managing different aspects of COVID-19 crisis
Mohammad Moradi, Reza Golmohammadi, Ali Najafi, et al.
Informatics in Medicine Unlocked (2022) Vol. 28, pp. 100862-100862
Open Access | Times Cited: 55
Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19
Noelia Silva-Pilipich, Uxue Beloki, Laura Salaberry, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 318-318
Open Access | Times Cited: 9
The active lung microbiota landscape of COVID-19 patients through the metatranscriptome data analysis
Yang Han, Zhilong Jia, Jinlong Shi, et al.
Bioimpacts (2021) Vol. 12, Iss. 2, pp. 139-146
Open Access | Times Cited: 55
The Adjuvant Effects on Vaccine and the Immunomodulatory Mechanisms of Polysaccharides From Traditional Chinese Medicine
Danyang Wang, Yonghui Liu, Wei Zhao
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 52
Subtractive Proteomics and Reverse-Vaccinology Approaches for Novel Drug Target Identification and Chimeric Vaccine Development against Bartonella henselae Strain Houston-1
Sudais Rahman, Chien-Chun Chiou, Shabir Ahmad, et al.
Bioengineering (2024) Vol. 11, Iss. 5, pp. 505-505
Open Access | Times Cited: 7
Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach
Reem AlJindan, Abeer M. Al‐Subaie, Ahoud I. Al-Ohali, et al.
Computers in Biology and Medicine (2021) Vol. 135, pp. 104654-104654
Open Access | Times Cited: 41
Advances of Reverse Vaccinology for mRNA Vaccine Design against SARS-CoV-2: A Review of Methods and Tools
Maria Karolaynne da Silva, Daniel Melo de Oliveira Campos, Shopnil Akash, et al.
Viruses (2023) Vol. 15, Iss. 10, pp. 2130-2130
Open Access | Times Cited: 14
Engineering and design of promising T-cell-based multi-epitope vaccine candidates against leishmaniasis
Esmaeil Roohparvar Basmenj, Mahshid Arastonejad, Mina Mamizadeh, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Leveraging the immunoinformatics approach for designing the SARS-CoV-2 omicron-specific antigenic cassette of mRNA vaccine
Rucha M. Wadapurkar, Sanjay Singh, Ajay Singh
Vaccine (2024) Vol. 42, Iss. 7, pp. 1630-1647
Closed Access | Times Cited: 5
Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
Taimoor Ashraf Khan, Abbas Khan, Jawad Khaliq Ansari, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2375-2375
Open Access | Times Cited: 19
Self-amplifying mRNA vaccines: Mode of action, design, development and optimization
Mohammad M. Pourseif, Yosef Masoudi-Sobhanzadeh, Erfan Azari, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 11, pp. 103341-103341
Closed Access | Times Cited: 19
Computational Modeling and Evaluation of Potential mRNA and Peptide‐Based Vaccine against Marburg Virus (MARV) to Provide Immune Protection against Hemorrhagic Fever
Faisal F. Albaqami, Ali Altharawi, Hassan N. Althurwi, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 13
TgVax452, an epitope-based candidate vaccine targeting Toxoplasma gondii tachyzoite-specific SAG1-related sequence (SRS) proteins: immunoinformatics, structural simulations and experimental evidence-based approaches
Hamidreza Majidiani, Mohammad M. Pourseif, Bahareh Kordi, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
A model for pH coupling of the SARS-CoV-2 spike protein open/closed equilibrium
Jim Warwicker
Briefings in Bioinformatics (2021) Vol. 22, Iss. 2, pp. 1499-1507
Open Access | Times Cited: 25
Microalgae as an Efficient Vehicle for the Production and Targeted Delivery of Therapeutic Glycoproteins against SARS-CoV-2 Variants
Jaber Dehghani, Ali Movafeghi, Elodie Mathieu‐Rivet, et al.
Marine Drugs (2022) Vol. 20, Iss. 11, pp. 657-657
Open Access | Times Cited: 18
Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach
Ysrafil Ysrafil, Zulfiayu Sapiun, Indwiani Astuti, et al.
Bioimpacts (2022)
Open Access | Times Cited: 17
Gag HIV-1 Virus-like Particles and Extracellular Vesicles Functionalization with Spike Epitopes of SARS-CoV-2 Using a Copper-Free Click Chemistry Approach
Marc García-Trujillo, Jesús Lavado‐García, Arnau Boix‐Besora, et al.
Bioconjugate Chemistry (2025)
Closed Access
A novel multi-objective metaheuristic algorithm for protein-peptide docking and benchmarking on the LEADS-PEP dataset
Yosef Masoudi-Sobhanzadeh, Behzad Jafari, Sepideh Parvizpour, et al.
Computers in Biology and Medicine (2021) Vol. 138, pp. 104896-104896
Closed Access | Times Cited: 20
Vaccination with rEGVac elicits immunoprotection against different stages of Echinococcus granulosus life cycle: A pilot study
Mohammad M. Pourseif, Gholamali Moghaddam, Ahmad Nematollahi, et al.
Acta Tropica (2021) Vol. 218, pp. 105883-105883
Closed Access | Times Cited: 16
Structure-based drug repurposing against COVID-19 and emerging infectious diseases: methods, resources and discoveries
Yosef Masoudi-Sobhanzadeh, Aysan Salemi, Mohammad M. Pourseif, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 16
mRNA-Based Vaccine Designing against Epstein-Barr Virus to Induce an Immune Response Using Immunoinformatic and Molecular Modelling Approaches
Hassan N. Althurwi, Khalid M. Alharthy, Faisal F. Albaqami, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 20, pp. 13054-13054
Open Access | Times Cited: 12
Multi-epitope vaccine design against leishmaniasis using IFN-γ inducing epitopes from immunodominant gp46 and gp63 proteins
Amir Ahmad Dehghani, Mina Mamizadeh, Atena Karimi, et al.
Journal of Genetic Engineering and Biotechnology (2024) Vol. 22, Iss. 1, pp. 100355-100355
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top